NovoCure Limited NovoCure (NASDAQ: NVCR) Provides Update on Phase 3 Pivotal LUNAR Trial Shares of NovoCure Limited (NASDAQ: NVCR) skyrocketed 49.63% during the trading session of Tuesday. The strong performance of the firm has highlighted the positive sentiments of the investors.